The project has been housed in Counter Culture Labs, a community laboratory and makerspace in the Bay Area.

The project aims to develop both the methodology and hardware to allow communities and individuals to produce medical-grade insulin for the treatment of diabetes.

There is also potential for small-scale distributed production that may allow for improved insulin access in places with poor availability infrastructure.

The original patent for insulin was later sold by his collaborators for just $1 to the University of Toronto in an effort to make it as available as possible.

Insulin remains controlled by a small number of large pharmaceutical companies and sold at prices unaffordable to many who rely on it to live, particularly those without insurance.